The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels
- 1 November 2016
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 30 (6) , 421-429
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation (94213)
This publication has 99 references indexed in Scilit:
- Plasminogen activator inhibitor 1 and visceral obesity during pronounced weight loss after bariatric surgeryNutrition, Metabolism and Cardiovascular Diseases, 2012
- Human obesity and endothelium‐dependent responsivenessBritish Journal of Pharmacology, 2012
- Preferential Fat Deposition in Subcutaneous Versus Visceral Depots Is Associated with Insulin SensitivityThe Journal of Clinical Endocrinology & Metabolism, 2011
- Waist Circumference, BMI, and Visceral Adipose Tissue in White Women and Women of African DescentObesity, 2011
- Contributions of dysglycaemia, obesity, and insulin resistance to impaired endothelium‐dependent vasodilation in humansDiabetes/Metabolism Research and Reviews, 2011
- Release of Inflammatory Mediators by Human Adipose Tissue Is Enhanced in Obesity and Primarily by the Nonfat Cells: A ReviewMediators of Inflammation, 2010
- Dual‐energy X‐ray Absorptiometry and Anthropometric Estimates of Visceral Fat in Black and White South African WomenObesity, 2010
- Abdominal Subcutaneous Adipose Tissue: A Protective Fat Depot?Diabetes Care, 2009
- Beneficial Effects of Subcutaneous Fat Transplantation on MetabolismCell Metabolism, 2008
- The Degree of Masculine Differentiation of Obesities:Obesity Research, 1996